# Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)

> **NCT00446056** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 188 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MK0476, montelukast sodium / Duration of Treatment: 4 Weeks
- **DRUG:** Comparator: ketotifen / Duration of Treatment: 4 Weeks

## Key facts

- **NCT ID:** NCT00446056
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09-25
- **Primary completion:** 2004-06-16
- **Final completion:** 2004-06-16
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446056, "Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00446056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*